BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 20049841)

  • 21. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children.
    Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T
    Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.
    Lagger G; O'Carroll D; Rembold M; Khier H; Tischler J; Weitzer G; Schuettengruber B; Hauser C; Brunmeir R; Jenuwein T; Seiser C
    EMBO J; 2002 Jun; 21(11):2672-81. PubMed ID: 12032080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos.
    Ma P; Schultz RM
    Dev Biol; 2008 Jul; 319(1):110-20. PubMed ID: 18501342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of downregulation of HDAC6 expression on cell cycle, proliferation and migration of laryngeal squamous cell carcinoma].
    Yuan LL; Wang F; Li SL; Lou WH; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):430-5. PubMed ID: 22967444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
    Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
    Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
    Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
    J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
    Meng F; Sun G; Zhong M; Yu Y; Brewer MA
    Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy.
    Khabele D; Son DS; Parl AK; Goldberg GL; Augenlicht LH; Mariadason JM; Rice VM
    Cancer Biol Ther; 2007 May; 6(5):795-801. PubMed ID: 17387270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative and positive regulation of gene expression by mouse histone deacetylase 1.
    Zupkovitz G; Tischler J; Posch M; Sadzak I; Ramsauer K; Egger G; Grausenburger R; Schweifer N; Chiocca S; Decker T; Seiser C
    Mol Cell Biol; 2006 Nov; 26(21):7913-28. PubMed ID: 16940178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
    Huang R; Zhang X; Sophia S; Min Z; Liu X
    Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.
    Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R
    BMC Cancer; 2016 Aug; 16():617. PubMed ID: 27506904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HDAC3 positively regulates HE4 expression to promote ovarian carcinoma progression.
    Lou T; Zhuang H; Liu C; Zhang Z
    Arch Biochem Biophys; 2019 Oct; 675():108044. PubMed ID: 31302139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. X-radiation inhibits histone deacetylase 1 and 2, upregulates Axin expression and induces apoptosis in non-small cell lung cancer.
    Han Y; Zhang Y; Yang LH; Mi XY; Dai SD; Li QC; Xu HT; Yu JH; Li G; Zhao J; Han C; Yuan XM; Wang EH
    Radiat Oncol; 2012 Oct; 7():183. PubMed ID: 23110995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of siRNA-Mediated Knockdown of HDAC1 on the Biological Behavior of Esophageal Carcinoma Cell Lines.
    Wang X; Guo H; Liu W; Yang C; Yang L; Wang D; Wang X
    Med Sci Monit; 2016 Apr; 22():1291-6. PubMed ID: 27086779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
    Wu LM; Yang Z; Zhou L; Zhang F; Xie HY; Feng XW; Wu J; Zheng SS
    PLoS One; 2010 Dec; 5(12):e14460. PubMed ID: 21206745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
    Kikuchi J; Wada T; Shimizu R; Izumi T; Akutsu M; Mitsunaga K; Noborio-Hatano K; Nobuyoshi M; Ozawa K; Kano Y; Furukawa Y
    Blood; 2010 Jul; 116(3):406-17. PubMed ID: 20351311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms.
    Pinkerneil M; Hoffmann MJ; Deenen R; Köhrer K; Arent T; Schulz WA; Niegisch G
    Mol Cancer Ther; 2016 Feb; 15(2):299-312. PubMed ID: 26772204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
    Zhu S; Deng S; He C; Liu M; Chen H; Zeng Z; Zhong J; Ye Z; Deng S; Wu H; Wang C; Zhao G
    J Pathol; 2018 Jul; 245(3):349-360. PubMed ID: 29708271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation.
    Turgeon N; Blais M; Gagné JM; Tardif V; Boudreau F; Perreault N; Asselin C
    PLoS One; 2013; 8(9):e73785. PubMed ID: 24040068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.